AN2 Therapeutics (ANTX) Accumulated Expenses (2021 - 2026)
AN2 Therapeutics (ANTX) posted Accumulated Expenses of $1.75 million for Q2 2026, down 40.9% from $2.95 million a year earlier and down 1.1% from the prior quarter.
Powered by 
Analysis
AN2 Therapeutics (ANTX) Accumulated Expenses (2021 - 2026) Analysis & Trends
At the end of FY2025, AN2 Therapeutics' Accumulated Expenses came in at $2.05 million, down 53.9% from FY2024.
- Annual Accumulated Expenses shows a four-year compound annual growth rate of 10.0% (FY2021 to FY2025).
- In prior years, AN2 Therapeutics' Accumulated Expenses was $4.45 million in FY2024 (-33.3%), $6.68 million in FY2023 (+135.5%), $2.84 million in FY2022 (+102.8%) and $1.4 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Accumulated Expenses since Q4 2021.
- On a year-over-year basis, Accumulated Expenses has declined in each of the last nine quarters, with an average decline of 43.5% over the last eight quarters.
- The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q3 2023, with growth of 276.2%; the weakest was Q1 2026, with a decline of 56.3%.
- According to Business Quant data, Accumulated Expenses for the three prior quarters was $1.77 million (Q1 2026), $2.05 million (Q4 2025) and $2.71 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | AN2 Therapeutics | 193.16 Mn | 193.16 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.75 Mn |
| Mar 31, 2026 | 1.77 Mn |
| Dec 31, 2025 | 2.05 Mn |
| Sep 30, 2025 | 2.71 Mn |
| Jun 30, 2025 | 2.95 Mn |
| Mar 31, 2025 | 4.04 Mn |
| Dec 31, 2024 | 4.45 Mn |
| Sep 30, 2024 | 4.92 Mn |
| Jun 30, 2024 | 5.84 Mn |
| Mar 31, 2024 | 6.91 Mn |
| Dec 31, 2023 | 6.68 Mn |
| Sep 30, 2023 | 6.79 Mn |
| Jun 30, 2023 | 6.44 Mn |
| Mar 31, 2023 | 4.24 Mn |
| Dec 31, 2022 | 2.84 Mn |
| Sep 30, 2022 | 1.81 Mn |
| Jun 30, 2022 | 1.80 Mn |
| Mar 31, 2022 | 2.10 Mn |
| Dec 31, 2021 | 1.40 Mn |
API Access
AN2 Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ANTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "ANTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ANTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();